R01 HL060906/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2000	1
2008	7
2009	6
2010	5
2011	6
2012	5
2013	4
2014	5
2015	1
2016	2
2017	1
2019	1
2024	0

1

This is not Dr. Conn's aldosterone anymore.

Brown NJ. Brown NJ. Trans Am Clin Climatol Assoc. 2011;122:229-43. Trans Am Clin Climatol Assoc. 2011. PMID: 21686229 Free PMC article. Review.

2

Aldosterone and inflammation.

Gilbert KC, Brown NJ. Gilbert KC, et al. Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):199-204. doi: 10.1097/med.0b013e3283391989. Curr Opin Endocrinol Diabetes Obes. 2010. PMID: 20422780 Free PMC article. Review.

3

Human PAH is characterized by a pattern of lipid-related insulin resistance.

Hemnes AR, Luther JM, Rhodes CJ, Burgess JP, Carlson J, Fan R, Fessel JP, Fortune N, Gerszten RE, Halliday SJ, Hekmat R, Howard L, Newman JH, Niswender KD, Pugh ME, Robbins IM, Sheng Q, Shibao CA, Shyr Y, Sumner S, Talati M, Wharton J, Wilkins MR, Ye F, Yu C, West J, Brittain EL. Hemnes AR, et al. JCI Insight. 2019 Jan 10;4(1):e123611. doi: 10.1172/jci.insight.123611. JCI Insight. 2019. PMID: 30626738 Free PMC article.

4

The renin-angiotensin-aldosterone system and glucose homeostasis.

Luther JM, Brown NJ. Luther JM, et al. Trends Pharmacol Sci. 2011 Dec;32(12):734-9. doi: 10.1016/j.tips.2011.07.006. Epub 2011 Aug 29. Trends Pharmacol Sci. 2011. PMID: 21880378 Free PMC article. Review.

5

Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.

Brown NJ. Brown NJ. Nat Rev Nephrol. 2013 Aug;9(8):459-69. doi: 10.1038/nrneph.2013.110. Epub 2013 Jun 18. Nat Rev Nephrol. 2013. PMID: 23774812 Free PMC article. Review.

6

Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapies.

Brown NJ. Brown NJ. J Am Soc Hypertens. 2012 May-Jun;6(3):163-8. doi: 10.1016/j.jash.2012.02.003. Epub 2012 Mar 19. J Am Soc Hypertens. 2012. PMID: 22433315 Free PMC article. Review.

7

Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension.

Gilbert K, Nian H, Yu C, Luther JM, Brown NJ. Gilbert K, et al. J Hypertens. 2013 Apr;31(4):820-9. doi: 10.1097/HJH.0b013e32835e8227. J Hypertens. 2013. PMID: 23385647 Free PMC article. Clinical Trial.

8

Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.

Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ. Luther JM, et al. Kidney Int. 2012 Sep;82(6):643-51. doi: 10.1038/ki.2012.170. Epub 2012 May 23. Kidney Int. 2012. PMID: 22622494 Free PMC article.

9

Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.

Schoenhard JA, Asselbergs FW, Poku KA, Stocki SA, Gordon S, Vaughan DE, Brown NJ, Moore JH, Williams SM. Schoenhard JA, et al. Hum Genet. 2008 Dec;124(5):479-88. doi: 10.1007/s00439-008-0573-x. Epub 2008 Oct 25. Hum Genet. 2008. PMID: 18953568 Free PMC article.

10

Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome.

Ayers K, Byrne LM, DeMatteo A, Brown NJ. Ayers K, et al. Hypertension. 2012 Apr;59(4):893-8. doi: 10.1161/HYPERTENSIONAHA.111.189589. Epub 2012 Feb 21. Hypertension. 2012. PMID: 22353614 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year